Oscar Health CEO Bertolini Executes $35.7 Million Stock Divestiture Amid Market Momentum
Mark T. Bertolini, the Chief Executive Officer of Oscar Health, Inc. (NASDAQ: OSCR), concluded a series of stock transactions totaling $35,767,321 on June 29 and June 30, 2026. The divestiture of 1,238,996 Class A Common Stock shares was executed to satisfy tax withholding requirements linked to the vesting of performance stock units. This executiv…